DNM1L and Parkinson disease: We also verified that the ROCK1 activation inhibitor Y-27632 has a therapeutic effect on a PD mouse model by suppressing Drp1-mediated aberrant mitochondrial fission and dopaminergic nerve cell apoptosis.